文献速递产科

慢性高血压孕妇早产型子痫前期的一级预防与预测

First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension.
PubMed 文献 · Ultrasound Obstet Gynecol · 2026-03-28

评估阿司匹林对慢性高血压孕妇因早产型子痫前期分娩孕周的影响,以及 FMF 早孕期竞争风险模型的预测效能。结果显示阿司匹林可平均延迟分娩 3.6 周,FMF 模型 AUC 为 0.819,能有效区分高低风险人群。

要点

  • 慢性高血压孕妇使用阿司匹林可使因早产型子痫前期分娩平均延迟 3.6 周。
  • FMF 早孕期竞争风险模型在慢性高血压孕妇中 AUC 达 0.819。
  • 风险分层主要受平均动脉压和胎盘生长因子影响,子宫动脉搏动指数贡献较小。

核心结论

  • 慢性高血压孕妇应用阿司匹林可延迟因早产型子痫前期导致的分娩。
  • FMF 早孕期竞争风险模型在慢性高血压孕妇中可有效识别早产型子痫前期低危和高危个体。

研究设计与样本

  • 研究类型为基于两项多中心早孕期子痫前期筛查研究数据的二次分析。
  • 阿司匹林疗效评估采用贝叶斯推断方法。
  • FMF 模型评估采用区分度、校准度和决策曲线分析。

主要发现

  • 慢性高血压孕妇中 58 例(10.4%)发生早产型子痫前期。
  • 阿司匹林延迟因子痫前期分娩的平均时间为 3.6 周(95% 可信区间 0.2-6.6 周),获益后验概率为 98%。
  • FMF 模型区分度良好,AUC 为 0.819(95% CI 0.763-0.874),校准度可接受。
  • FMF 模型净获益高于全部治疗的策略。
  • 慢性高血压孕妇中 21.8% 被归为早产型子痫前期低风险(< 1/100),以初产妇和无子痫前期史经产妇为主。

关键数值与推荐

  • 慢性高血压定义为孕妇存在慢性高血压病史。
  • 早产型子痫前期低风险阈值为预测风险 < 1/100。
  • FMF 模型纳入的生物标志物为 MAP、UtA-PI 和 PlGF。
  • 贝叶斯分析显示阿司匹林延迟分娩 3.6 周(95% 可信区间 0.2-6.6 周)。

临床怎么用

  • 慢性高血压孕妇可在早孕期使用 FMF 竞争风险模型进行早产型子痫前期风险分层。
  • 被识别为高风险的慢性高血压孕妇应考虑阿司匹林预防性治疗。
  • 低风险慢性高血压孕妇可能无需强化干预,但需结合临床综合判断。

局限性

  • 数据来源于原始研究,未在原文中报告具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the effect of aspirin on gestational age at delivery due to preterm pre-eclampsia (PE) in women with chronic hypertension (CH), to assess the predictive performance of the Fetal Medicine Foundation (FMF) first-trimester competing-risks model for preterm PE in this high-risk group and to evaluate how parity, previous PE and biomarker values influence individualized risk estimates. METHODS: We analyzed data from two multicenter first-trimester PE screening studies: the Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-based Preeclampsia Prevention trial and the Screening Program for Preeclampsia trial. The effect of aspirin on gestational age at delivery due to PE was assessed using Bayesian inference. The screening performance of the FMF model was evaluated by discrimination, calibration and decision-curve analysis. The influence of parity, previous PE and biomarkers (mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI) and placental growth factor (PlGF)) on risk classification was explored using empirical data and Monte Carlo simulations with generalized additive models. RESULTS: The combined dataset included 51 024 women with a singleton pregnancy, of whom 556 (1.1%) had CH. Among the women with CH, 58 (10.4%) developed preterm PE. Bayesian analysis indicated that aspirin delayed delivery due to PE by a mean of 3.6 (95% credible interval, 0.2-6.6) weeks, with a 98% posterior probability of benefit. The FMF model demonstrated good discrimination (area under the receiver-operating-characteristics curve, 0.819 (95% CI, 0.763-0.874)), adequate calibration and higher net benefit compared with a treat-all approach. Overall, 21.8% of women with CH were classified as low risk (< 1 in 100) for preterm PE, consisting mostly of nulliparous women and parous women without previous PE. Predicted risks for preterm PE were strongly influenced by MAP and PlGF, with UtA-PI contributing to a lesser extent. CONCLUSIONS: In women with CH, aspirin can delay delivery due to preterm PE, and first-trimester risk assessment using the FMF competing-risks model reliably identifies low- and high-risk individuals. The predicted risk is driven primarily by MAP and PlGF, supporting risk stratification and individualized management in early pregnancy. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rolnik, Gil-Pugliese, Syngelaki, et al. First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension. Ultrasound Obstet Gynecol. 2026. PMID: 41903191. doi:10.1002/uog.70212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。